Aclidinium bromide is a medication used in the treatment of chronic obstructive pulmonary disease (COPD). The chemical name for aclidinium bromide is (3R)-3-[(hydroxydi-2-thienylacetyl)oxy]-1-(3-phenoxypropyl)-1-azoniabicyclo[2.2.2]octane bromide. It has the molecular formula C26H30BrNO4S2 and a formula weight of 564.56 g/mol. The CAS number for aclidinium bromide is 320345-99-1.
Top ten keywords from Google and Synonyms:
Health benefits of this product: Aclidinium bromide is primarily used to treat the symptoms associated with COPD, such as shortness of breath, wheezing, and coughing. It is a type of bronchodilator that works by relaxing the muscles around the airways to make breathing easier. Aclidinium bromide is also a long-acting muscarinic antagonist (LAMA) which means it can provide relief for up to 24 hours after each dose.
Potential effects: Aclidinium bromide is effective at improving lung function and reducing symptoms associated with COPD. This medication can help people with COPD breathe easier, which can improve their quality of life. Aclidinium bromide has been shown to be effective in reducing exacerbations of COPD, which are sudden worsening of symptoms that require medical attention.
Product mechanism: Aclidinium bromide works by blocking the action of acetylcholine, a neurotransmitter that causes the muscles around the airways to tighten. By blocking the action of acetylcholine, aclidinium bromide relaxes the muscles, making it easier to breathe. This medication is a type of bronchodilator that works specifically on the airways in the lungs, which helps to improve breathing function.
Safety: Aclidinium bromide is generally considered safe for most people when used as directed. However, like all medications, there are potential side effects and risks associated with its use. It is important to discuss any concerns or questions with a healthcare provider before starting this medication.
Side effects: The most common side effects of aclidinium bromide include headache, cough, and constipation. Other potential side effects include dry mouth, blurred vision, urinary retention, and allergic reactions. These side effects are usually mild and go away on their own, but if they persist or become severe, medical attention should be sought.
Dosing information: The recommended dose of aclidinium bromide is one inhalation twice daily using a dry powder inhaler device. It is important to follow the dosing instructions provided by a healthcare provider and not exceed the recommended dose. If a dose is missed, it should be taken as soon as remembered, unless it is almost time for the next dose, in which case the missed dose should be skipped.
Conclusion: Aclidinium bromide is an effective medication for the treatment of COPD that works by relaxing the muscles around the airways in the lungs. It is a long-acting muscarinic antagonist (LAMA), meaning it can provide relief for up to 24 hours after each dose. While generally considered safe, there are potential side effects associated with its use, and it is important to discuss any concerns with a healthcare provider. Overall, aclidinium bromide is an important medication for people with COPD that can improve their quality of life by reducing symptoms and exacerbations.
